First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Helga Droogendijk et al.|The Lancet Oncology|2023Cited by 168
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trialJ Michiel Zeeuw, Geert Kazemier, Ruby Kemna et al.|European Journal of Cancer|2025Cited by 3